Research Snapshot: Study points to strategy to overcome lung cancer drug resistance
The study points to a new therapeutic strategy to reverse chemotherapy resistance in non-small cell lung cancer.
All Posts by
The study points to a new therapeutic strategy to reverse chemotherapy resistance in non-small cell lung cancer.
The gathering empowered community members by providing information about breast, ovarian and cervical cancers.
The honor is among the most distinctive in academia and recognizes extraordinary impact and achievement across disciplines.
The podcast discusses the NRG-GI008 study evaluating what chemotherapy to recommend based on circulating tumor DNA after colon cancer surgery.
Dina Khalaf, M.D., will provide personalized treatments for patients with bone marrow failure and blood cancers like leukemia.
Wei Shao, Ph.D., has dedicated his career to leveraging artificial intelligence to enhance medical imaging.
The trial will test a novel UF-developed mRNA lipid nanoparticle (RNA-LP) in two pediatric cancers.
In an interview with OncLive, Coy Heldermon, M.D., Ph.D., discusses a trial evaluating epidiferphane given with taxane chemotherapy in breast cancer.
Ramon Sun, Ph.D., and Matthew Gentry, Ph.D., used a high-content spatial metabolomics platform to look at the link between diet and lung cancer.
The grant funds his work developing next-generation methods for using mass spectrometry to better understand health and disease.